Recombinant Human Interleukin-11 For

Name: Recombinant Human Interleukin-11 For in Chemotherapy-induced Thrombocytopenia
Creator: Floatz
License: https://terminal.floatz.ai/terms

Chemotherapy-induced Thrombocytopenia

Liaoning Cancer Hospital & InstituteDormant

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 89/ 100

Competitive context

19 Active assets in the Chemotherapy-induced Thrombocytopenia cohort.

Asset / Sponsor	Phase	Rating
Recombinant Human Thrombopoietin Sun Yat-sen University	Phase 4	BBB
sb-497115-gr Institute of Hematology & Blood Diseases Hospital, China	Phase 4	BB
FILGRASTIM OHSU Knight Cancer Institute	Phase 2	BB
Avatrombopag Second Affiliated Hospital of Guangzhou Medical University	Phase 4	BB
Hetrombopag Sun Yat-sen University	Phase 3	BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →